Ferrous gluconate 300mg tablets

国: イギリス

言語: 英語

ソース: MHRA (Medicines & Healthcare Products Regulatory Agency)

即購入

製品の特徴 製品の特徴 (SPC)
31-07-2019

有効成分:

Ferrous gluconate

から入手可能:

Alliance Healthcare (Distribution) Ltd

ATCコード:

B03AA03

INN(国際名):

Ferrous gluconate

投薬量:

300mg

医薬品形態:

Oral tablet

投与経路:

Oral

クラス:

No Controlled Drug Status

処方タイプ:

Valid as a prescribable product

製品概要:

BNF: 09010101

情報リーフレット

                                PATIENT INFORMATION LEAFLET
FERROUS GLUCONATE 300MG TABLETS
READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS
MEDICINE BECAUSE IT CONTAINS
IMPORTANT INFORMATION FOR YOU.
ALWAYS TAKE THIS MEDICINE EXACTLY AS DESCRIBED IN THIS LEAFLET OR AS
YOUR DOCTOR OR PHARMACIST
HAS TOLD YOU.
• KEEP THIS LEAFLET. YOU MAY NEED TO READ IT AGAIN.
• IF YOU HAVE ANY FURTHER QUESTIONS, ASK YOUR DOCTOR OR PHARMACIST. • THIS MEDICINE HAS BEEN PRESCRIBED FOR YOU ONLY. DO NOT PASS IT ON
TO OTHERS. IT MAY HARM THEM, EVEN IF THEIR SIGNS OF ILLNESS ARE THE SAME AS YOURS.
• IF YOU GET ANY SIDE EFFECTS TALK TO YOUR DOCTOR OR PHARMACIST.
THIS INCLUDES ANY POSSIBLE SIDE EFFECTS NOT LISTED IN THIS LEAFLET. SEE SECTION 4.
• YOU MUST TALK TO A DOCTOR IF YOU DO NOT FEEL BETTER OR IF YOU FEEL
WORSE. WHAT IS IN THIS LEAFLET
1. What Ferrous Gluconate 300mg Tablets are and what they are used for
2. What you need to know before you take Ferrous Gluconate 300mg
Tablets
3. How to take Ferrous Gluconate 300mg Tablets
4. Possible side effects
5. How to store Ferrous Gluconate 300mg Tablets
6. Contents of the pack and other information
1.
2.
3.
4.
5.
6. WHAT FERROUS GLUCONATE 300MG TABLETS ARE AND WHAT THEY ARE USED FOR
Ferrous Gluconate 300mg Tablets are used for
the treatment and prevention of iron deficiency.
Ferrous Gluconate is a form of iron. Iron is
necessary for the production of haemoglobin
(protein in red blood cells), which carries oxygen
around the body. Iron is involved in the
formation of myoglobin, a pigment that stores
oxygen in muscles for use during exercise. WHAT YOU NEED TO KNOW BEFORE YOU TAKE FERROUS GLUCONATE 300MG TABLETS
DO NOT TAKE FERROUS GLUCONATE 300MG
TABLETS:
• if you are allergic (hypersensitive) to
ferrous gluconate, medicines containing
iron or any of the other ingredients in this
medicine (See section 6)
• if you have a build up of too much iron in
the body (haemochromatosis)
• if you suffer from iron storage
(haemosiderosis) or absorption
(haemoglobinuria)
• if you have anaemia not caused by
                                
                                完全なドキュメントを読む
                                
                            

製品の特徴

                                SUMMARY OF PRODUCT CHARACTERISTICS
1
NAME OF THE MEDICINAL PRODUCT
Ferrous Gluconate 300mg Tablets
2.
QUALITATIVE AND QUANTITATIVE COMPOSITION
Each tablet contains 300mg ferrous gluconate.
Excipients with known effect: contains sucrose and ponceau 4R red
(E124).
For a full list of excipients, see section 6.1.
3.
PHARMACEUTICAL FORM
Coated tablet.
Appearance: Red, circular, biconvex, sugar-coated tablet.
4
CLINICAL PARTICULARS
4.1
THERAPEUTIC INDICATIONS
Ferrous Gluconate 300mg Tablets are indicated for the prevention and
treatment of iron
deficiency states.
4.2
POSOLOGY AND METHOD OF ADMINISTRATION
ADULTS AND THE ELDERLY
_Prophylactic_: 2 tablets daily.
_Therapeutic_: 4-6 tablets daily in divided doses.
CHILDREN (AGED 6-12 YEARS)
_Prophylactic: _1 or 2 tablets daily.
_Therapeutic: _3 tablets daily in divided doses.
Ferrous Gluconate 300mg Tablets are best taken about one hour before
meals.
_ _
_ _
_Method of administration _
The route of administration for Ferrous Gluconate 300mg tablets is
oral.
4.3
CONTRAINDICATIONS
Hypersensitivity to the active ingredient ferrous gluconate or to any
of the excipients listed in section
6.1.
Iron preparations are contra-indicated in patients with
haemochromatosis, iron storage or absorption
diseases such as and haemosiderosis or haemoglobinuria.
Iron is contraindicated in patients receiving repeated blood
transfusions, or in patients receiving
parenteral iron therapy or to patients with anaemias not produced by
iron deficiency (some conditions,
such as thalassemia may cause excess storage of iron).
Alcoholism and hepatitis.
Iron preparations are contraindicated in active peptic ulcer, regional
enteritis and ulcerative colitis.
Ferrous Gluconate Tablets should not be used in patients with anaemia
not produced by iron
deficiency unless iron deficiency is also present.
4.4
SPECIAL WARNINGS AND PRECAUTIONS FOR USE
Large doses may have irritant/corrosive effect on gastro-intestinal
mucosa which can lead to necrosis
and perforation.
Ferrous Gluconate should be used with caution in pa
                                
                                完全なドキュメントを読む
                                
                            

この製品に関連するアラートを検索

ドキュメントの履歴を表示する